Skip to content
Search

Latest Stories

England’s top mental health nurse urges people to look out for dementia warning signs

England’s top mental health nurse urges people to look out for dementia warning signs

NHS staff diagnosed 463,797 people aged over 65 with dementia in November 2023, up more than 41,000 compared to the same period last year.

Dementia is an extremely deceptive disease that develops slowly and may go unnoticed in people, said NHS mental health director Claire Murdoch, while urging people to look out for the vital warning signs of this condition among family and friends over Christmas.


Common early symptoms of dementia may include emotional change, forgetfulness, difficulty concentrating, struggling to follow a conversation or find the right word, being confused about time and place, the health service has cautioned.

An increasing number of people have been diagnosed with dementia in England since the start of the pandemic, following a drive by the NHS England to increase diagnosis rates.

In November 2023, NHS staff diagnosed 463,797 people aged over 65 with dementia, up more than 41,000 compared to the same period last year, according to the figures revealed by the health service.

To identify more people with dementia, the NHS launched 14 pilots across the country which involve health professionals going into care homes to assess older adults who may have missed checks during the pandemic.

The target is to complete diagnosis of 66.7 per cent of people over 65 for dementia by next year, and three regions in London, North West, and North East and Yorkshire have already achieved it.

The NHS has also launched a £5m project to introduce new blood tests that can diagnose Alzheimer’s disease.

It will be easier to spot dementia warning signs when families and friends get together over the festive season, Murdoch said.

“There are lots of reasons why people might be forgetful or absent-minded at such a busy time of the year, but it could also be the sign that something can be wrong.

“Getting a diagnosis for dementia is the first step in supporting people with a wide range of NHS services able to help.

“Thanks to the efforts of NHS staff, tens of thousands more people are now getting a dementia diagnosis than this time last year which opens up doors to further support for patients and their families who experience this heart-breaking disease.

“If you have noticed that someone has symptoms, please encourage them to visit their GP for an assessment – the sooner someone is seen the quicker the NHS can help,” she added.

NHS data showed that around 944,000 individuals are currently living with dementia in the UK, and over 750,000 of these patients are from England.

“Dementia is the UK’s biggest killer,” said James White, Head of National Influencing at Alzheimer’s Society, adding that it can often be mistaken for simply old age but “it’s not a natural part of ageing and it doesn’t just affect older people.”

Despite so many people living with dementia in the UK, there’s a lack of awareness of its symptoms, noted Dr Susan Mitchell, Head of Policy – Prevention, Early Detection and Diagnosis at Alzheimer’s Research UK.

“For example, one in two people aren’t aware that memory loss as a sign of the condition, and there’s even lower awareness of other signs, such as problems in communicating, low mood and anxiety, and confusion,” she added.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less